Dr.Vikram Chaudhari
@DrVAChaudhari
Followers
1K
Following
1K
Media
12
Statuses
380
Professor,GI and HPB Surgical Oncology,Tata Memorial Hospital , Mumbai, India
Mumbai, India
Joined July 2021
Are you here yet? #APHPBA2025 has began queen ! Don't miss the opening ceremony with @Shrikhande_SV and Rene Adam followed by the Living legends! #aphpba @IHPBA @hpbsurgeon1 @Manishbhandare4 @hitoen9 @JSHBPS @aphpba2025 @APHPBA2023 @APHPBA_2021 @aphpba2027 @aphpbacongress
0
8
14
Less than 4 weeks to go for Oncosurg 2025 20–22 November | ACTREC–TMC, Navi Mumbai Abstract submission (Video category) extended till 30th October 2025 Join us for live cancer surgeries, global experts and cutting-edge discussions Register now: https://t.co/OZ1NsxMuno
1
9
12
A-PHPBA 2025: Symposium A9 – Connecting the World of HPB! Join us in Bangkok for an inspiring 90-minute session celebrating mentorship, diversity, and collaboration in HPB surgery. Forging Global Excellence, Building Connections, Advancing Together! #aphpba2025
0
6
10
Wonderful time at IASO-NATCON 2025 National conference in Surgical Oncology, Goa! Delivered 3 talks 2 videos & judged a surgical video session 1) Peritoneum - anatomical entity or a full fledged organ? 2) Electrosurgery - What a surgeon shud know in the Operating theatre
1
2
19
@Shrikhande_SV @NbmerchantMD What an amazing team at @TataMemorial led by @Shrikhande_SV and @DrVAChaudhari @Manishbhandare4
0
3
8
Thanks to @SOCSurgOnc & IASO for an amazing visit to India. Spent time at @TataMemorial visiting with an outstanding surg onc team, followed by IASO-NATCON. New friends, excellent learning & amazing food! Thanks for the hospitality @Shrikhande_SV @DrVAChaudhari @bermar01 Dr. Are
2
3
24
Surgical feasibility may not always translate into surgical appropriateness. Do read our latest publication where we aim to select the the patient’s who may not benefit from a surgical resection. Link 👇🏽 https://t.co/mXK9SPDwC6
@DrGuruduttVarty
1
5
6
🚨New from TMH! Can we predict futile Surgery in resectable gallbladder cancers? Our findings published in @ejsotweets Link👇🏽 https://t.co/6GTc7L2nUY Resectable ≠ Beneficial @Shraddha_234 @drmgoel @Hepbilisurg_TMH Thread👇🏽 @Shrikhande_SV @cspramesh @TataMemorial
3
20
41
Wonderful conversation with @Shrikhande_SV on his passion and hardwork with pancreas...
1
6
6
@ISGPS_news @APHPBA @EAHPBA @for_surgeons @OncoShravan @aamirparray18 @Manishbhandare4 @DrGuruduttVarty @DrVAChaudhari
@drsadiqs Thank you so much. Enjoyed revisiting the journey of pancreas surgery over 2 decades. Truly honoured!
0
2
2
💡 Pancreatic cancer’s big question: Which neoadjuvant is best? PREOPANC-2 says… both. 👥 Population • 369 pts | Resectable / borderline PDAC • Phase III | 19 Dutch centers 🧪 Arms 1️⃣ FOLFIRINOX (8 cycles) ➡️ Surgery (no adjuvant) 2️⃣ Gemcitabine-CRT (3 cycles + RT) ➡️
2
79
183
👉🏻 don’t miss this one!
⏳ 8 weeks to go! ONCOSURG 2025 | 20–22 Nov | @ACTREC_TMC Theme: Balancing Oncological Safety with Function Preservation 🔹 18–20 live cancer surgeries 🔹 Robotic liver & thyroid surgeries (Intl faculty) 🔹 Hands-on workshops & video awards 👉 Register: https://t.co/52YNWPodOy
0
4
10
🤔 Ever heard of the Will Rogers phenomenon in oncology? It’s the magic trick of stage migration. 🔍 A patient once called “Stage II” by old scans… ➡️ New PET-CT spots hidden nodes → upgraded to Stage III. Now watch the illusion unfold: ✨ Stage II survival ↑ (sickest pts
3
17
86
From studying Shackelford’s as a surgical gastroenterology student to now contributing a chapter to its latest edition— brings immense pride and sense of fulfilment for me. Thank you @SyedAAhmad5 @Shrikhande_SV. Great job @DrGuruduttVarty. @Manishbhandare4
Truly grateful for the opportunity to contribute to the 9th edi. of Shackelford’s Surgery of the Alimentary Tract This honour will stay with me for a lifetime. Thank you Prof @Shrikhande_SV The journey with you all is as beautiful as the result @DrVAChaudhari @Manishbhandare4
4
6
35
📊 T1 ampullary cancer @ Tata Memorial: 5-yr OS 74.5% | 5-yr RFS 78.4% | Recurrence 19.6% LN+ = Remains key for OS & RFS PD remains standard despite 38% major complications Thank you for th oppurtunity. @Manishbhandare4 @Shrikhande_SV
@DrVAChaudhari @hpbjournal @TataMemorial
3
9
26
We deeply mourn the loss of Dr. Anita Borges, India's most illustrious oncopathologist. Her service to countless patients at TMH and beyond leave an indelible legacy. It was indeed fitting that she left for her heavenly abode doing what she was most passionate about, teaching 🙏
43
178
842
On the occasion of Teachers' day, we salute all the extraordinary teachers who have shaped @TataMemorial into what it is today, thank all trainees for continuously inspiring us to excel, and express gratitude to our patients for placing their faith in us 🙏
2
9
62
A-PHPBA 2025 Scientific Highlights Discover inspiring presentations from leading experts around the world, along with outstanding abstracts that will challenge and inspire your thinking. Explore the scientific highlights now: https://t.co/c5C3zhA54v
#aphpba2025
0
3
3
Surgical Residents and fellows should learn this skill. Dr Shravan N is a master. Looking forward.
Learn from the expert: how to make your operative videos. https://t.co/YFGKNbCCpH
@OncoShravan @SyedAAhmad5 @Shrikhande_SV @pjshukla
2
0
12
Our new paper in Annals of Hepato-Biliary-Pancreatic Surgery introduces the “Total Non-Division Technique” of Pancreaticoduodenectomy – combining SMA-first + TMpE for safer, radical, and reversible surgery. 🔗 https://t.co/gZ9tOVwxwN
#Surgery #CancerResearch #india #gcri
1
3
17